Community‐based pharmacists' role in deprescribing: A systematic review DOI Open Access
Iva Bužančić, Ingrid Kummer, Margita Držaić

и другие.

British Journal of Clinical Pharmacology, Год журнала: 2021, Номер 88(2), С. 452 - 463

Опубликована: Июнь 22, 2021

Community-based pharmacists are an important stakeholder in providing continuing care for chronic multi-morbid patients, and their role is steadily expanding. The aim of this study to examine the literature exploring community-based pharmacist-initiated and/or -led deprescribing evaluate impact on success clinical outcomes.Library trials databases were searched from inception March 2020. Studies included if they explored adults, by available English. Two reviewers extracted data independently using a pre-agreed extraction template. Meta-analysis was not performed due heterogeneity designs, types intervention outcomes.A total 24 studies review. Results grouped based method into four categories: educational interventions; interventions involving medication review, consultation or therapy management; pre-defined pharmacist-led collaborative interventions. All resulted greater discontinuation medications comparison usual care. Educational reported financial benefits as well. Medication review pharmacist can lead successful high-risk medication, but do affect risk rate falls, hospitalisations, mortality quality life. Pharmacist-led patients with mental illness, resulting improves anticholinergic side effects, memory Pre-defined did reduce healthcare resource consumptions contribute savings. Short follow-up periods prevent evaluation long-term sustainability interventions.This systematic suggests that valuable partners collaborations, necessary monitoring throughout tapering post-follow-up ensure intervention.

Язык: Английский

Health care professionals' attitudes towards deprescribing in older patients with limited life expectancy: A systematic review DOI Open Access
Carina Lundby, Trine Graabæk, Jesper Ryg

и другие.

British Journal of Clinical Pharmacology, Год журнала: 2019, Номер 85(5), С. 868 - 892

Опубликована: Янв. 10, 2019

Aims The aim of this systematic review was to explore health care professionals' attitudes towards deprescribing in older people with limited life expectancy. Methods A literature search conducted from inception December 2017 using MEDLINE, EMBASE and CINAHL. Studies were included if they specifically concerned (≥65 years) expectancy, including those residing any type aged facility, or based on representative patient profiles. Results analyzed inspired by the Joanna Briggs Institute's method for synthesis qualitative data. characterized a checklist reporting research. Eight studies included. Six explored views general, two focused psychotropic agents. All eight physicians, mostly general practitioners, while three also considered other professionals. Four themes related identified: (i) relative involvement; (ii) importance teamwork; (iii) self‐assurance skills; (iv) impact organizational factors. Within each these themes, 3–4 subthemes identified analysed. Conclusions Our results suggest that decisions engage activities expectancy depend multiple factors which are highly interdependent. Consequently, there is an urgent need more research how approach clinical practice within population.

Язык: Английский

Процитировано

49

Deprescribing conversations: a closer look at prescriber–patient communication DOI Open Access
Justin P. Turner,

Claude Richard,

Marie‐Thérèse Lussier

и другие.

Therapeutic Advances in Drug Safety, Год журнала: 2018, Номер 9(12), С. 687 - 698

Опубликована: Окт. 20, 2018

Little is known about the initiation, style and content of patient healthcare provider communication around deprescribing. We report findings from a analysis audio-recorded discussions proton pump inhibitor (PPI) benzodiazepine deprescribing in primary care.Participants were providers (n = 13) care practices 3) patients aged ⩾65 24) who chronic users PPIs or benzodiazepines. The EMPOWER educational brochures distributed prior to 15) after 9) patient's usual appointment. Conversations coded using MEDICODE analyze initiated different themes, whether they followed monologue dialogue style, what extent thematic addressed issues pertaining to: 'dosage/instructions,' 'medication action efficacy,' 'risk/adverse effects,' 'attitudes/emotions,' 'adherence' 'follow up.' Descriptive conversations was performed with comparison between received brochure before their appointments.Patients mostly women (67%) mean age 74 ± 6 years. For PPI users, education resulted greater proportion themes by (44% versus 17%) maintaining dialogue-style (48% 28%). Among conversation initiation (52% 47%) similar both groups. for revealed that focused less on more efficacy' necessity stopping benzodiazepines likely stagnate 'if' rather than 'how.'The varied suggesting will need tailor accordingly.

Язык: Английский

Процитировано

47

Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial DOI
Cathy Balsom, Nicole Pittman, Renee King

и другие.

International Journal of Clinical Pharmacy, Год журнала: 2020, Номер 42(4), С. 1153 - 1167

Опубликована: Июнь 3, 2020

Язык: Английский

Процитировано

43

Deprescribing interventions in primary health care mapped to the Behaviour Change Wheel: A scoping review DOI
Jennifer E. Isenor, Isaac Bai,

Rachel Cormier

и другие.

Research in Social and Administrative Pharmacy, Год журнала: 2020, Номер 17(7), С. 1229 - 1241

Опубликована: Сен. 22, 2020

Язык: Английский

Процитировано

40

Community‐based pharmacists' role in deprescribing: A systematic review DOI Open Access
Iva Bužančić, Ingrid Kummer, Margita Držaić

и другие.

British Journal of Clinical Pharmacology, Год журнала: 2021, Номер 88(2), С. 452 - 463

Опубликована: Июнь 22, 2021

Community-based pharmacists are an important stakeholder in providing continuing care for chronic multi-morbid patients, and their role is steadily expanding. The aim of this study to examine the literature exploring community-based pharmacist-initiated and/or -led deprescribing evaluate impact on success clinical outcomes.Library trials databases were searched from inception March 2020. Studies included if they explored adults, by available English. Two reviewers extracted data independently using a pre-agreed extraction template. Meta-analysis was not performed due heterogeneity designs, types intervention outcomes.A total 24 studies review. Results grouped based method into four categories: educational interventions; interventions involving medication review, consultation or therapy management; pre-defined pharmacist-led collaborative interventions. All resulted greater discontinuation medications comparison usual care. Educational reported financial benefits as well. Medication review pharmacist can lead successful high-risk medication, but do affect risk rate falls, hospitalisations, mortality quality life. Pharmacist-led patients with mental illness, resulting improves anticholinergic side effects, memory Pre-defined did reduce healthcare resource consumptions contribute savings. Short follow-up periods prevent evaluation long-term sustainability interventions.This systematic suggests that valuable partners collaborations, necessary monitoring throughout tapering post-follow-up ensure intervention.

Язык: Английский

Процитировано

40